Furthermore, researchers have observed higher levels of TMPRSS2 and ACE2 in the lesional skin of AD patients (25), potentially explaining their susceptibility to SARS-CoV-2 and the likelihood of experiencing more severe symptoms upon infection. This evidence concerns the gene TMPRSS2 and Alzheimer disease.